These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

66 related items for PubMed ID: 7875999

  • 1. [Can hyperlipidemia after heart transplantation be optimally and safely treated?].
    Wenke K, Thiery J, Arndtz N, Seidel D, Reichart B.
    Helv Chir Acta; 1994 Dec; 60(6):1163-8. PubMed ID: 7875999
    [Abstract] [Full Text] [Related]

  • 2. [Therapy of hypercholesterolemia after heart transplantation with the HMG-CoA reductase inhibitor simvastatin in long-term follow-up].
    Wenke K, Thiery J, Meiser B, Arndtz N, Seidel D, Reichart B.
    Z Kardiol; 1995 Feb; 84(2):130-6. PubMed ID: 7717016
    [Abstract] [Full Text] [Related]

  • 3. [Efficacy and tolerability of simvastatin and omega-3 fatty acid combination in patients with coronary disease, hypercholesterolemia and hypertriglyceridemia].
    Tomei R, Rossi L, Carbonieri E, Franceschini L, Cemin C, Ghebremariam-Tesfau K, Zardini P.
    Cardiologia; 1993 Dec; 38(12):773-8. PubMed ID: 8200011
    [Abstract] [Full Text] [Related]

  • 4. Cholesterol-lowering therapy after heart transplantation: a 12-month randomized trial.
    Pflugfelder PW, Huff M, Oskalns R, Rudas L, Kostuk WJ.
    J Heart Lung Transplant; 1995 Dec; 14(4):613-22. PubMed ID: 7578166
    [Abstract] [Full Text] [Related]

  • 5. Safety and efficacy of low dose simvastatin in cardiac transplant recipients treated with cyclosporine.
    Vanhaecke J, Van Cleemput J, Van Lierde J, Daenen W, De Geest H.
    Transplantation; 1994 Jul 15; 58(1):42-5. PubMed ID: 8036706
    [Abstract] [Full Text] [Related]

  • 6. Lipid-lowering effects of simvastatin and gemfibrozil in CAPD patients: a prospective cross-over study.
    Akçiçek F, Ok E, Duman S, Kürsad S, Unsal A, Alev M, Atabay G, Basçi A.
    Adv Perit Dial; 1996 Jul 15; 12():261-5. PubMed ID: 8865916
    [Abstract] [Full Text] [Related]

  • 7. [Effectiveness, tolerance and safety of simvastatin in comparison with bezafibrate in treatment of hypercholesterolemia].
    Lechleitner M, Sailer S, Irsigler H, Klein W, Patsch JR.
    Wien Med Wochenschr; 1995 Jul 15; 145(21):577-83. PubMed ID: 8560901
    [Abstract] [Full Text] [Related]

  • 8. [Simvastatin (MK-733), a new HMG-CoA reductase inhibitor, in the treatment of hypercholesterolemia in elderly patients with atherosclerosis].
    Giannini SD, de Góes JM, Dereviack BE, Machado C, Forti N, Diament J.
    Arq Bras Cardiol; 1990 Jun 15; 54(6):407-14. PubMed ID: 2288531
    [Abstract] [Full Text] [Related]

  • 9. Comparison of combined statin-fibrate treatment to monotherapy in patients with mixed hyperlipidemia.
    Kłosiewicz-Latoszek L, Szostak WB, Grzybowska B, Białobrzeska-Paluszkiewicz J, Wiśniewska B, Stolarska I.
    Kardiol Pol; 2004 Jun 15; 60(6):567-77. PubMed ID: 15334157
    [Abstract] [Full Text] [Related]

  • 10. A randomized, open-label study to evaluate the efficacy and safety of pitavastatin compared with simvastatin in Korean patients with hypercholesterolemia.
    Park S, Kang HJ, Rim SJ, Ha JW, Oh BH, Chung N, Cho SY.
    Clin Ther; 2005 Jul 15; 27(7):1074-82. PubMed ID: 16154486
    [Abstract] [Full Text] [Related]

  • 11. [Long term treatment of moderate to severe hypercholesterolemia with low dose statin. Comparison of simvastatin and pravastatin].
    Spagnolli W, Ramponi C, Focher C, Dal Piaz A, Torboli P, Miori R, De Venuto G.
    Recenti Prog Med; 1996 Nov 15; 87(11):538-42. PubMed ID: 9122535
    [Abstract] [Full Text] [Related]

  • 12. Effects of bezafibrate and of 2 HMG-CoA reductase inhibitors on lipoprotein (a) level in hypercholesterolemic patients.
    Branchi A, Rovellini A, Fiorenza AM, Sommariva D.
    Int J Clin Pharmacol Ther; 1995 Jun 15; 33(6):345-50. PubMed ID: 7582386
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia.
    Frohlich J, Brun LD, Blank D, Campeau L, Crockford P, Curnew G, Dafoe W, Davignon J, Dufour R, Emery G.
    Can J Cardiol; 1993 Jun 15; 9(5):405-12. PubMed ID: 8348392
    [Abstract] [Full Text] [Related]

  • 14. Clinical efficacy and pharmacokinetics of HMG-CoA reductase inhibitors in heart transplant patients treated with cyclosporin A.
    Regazzi MB, Iacona I, Campana C, Gavazzi A, Viganò M, Perani G.
    Transplant Proc; 1994 Oct 15; 26(5):2644-5. PubMed ID: 7940825
    [No Abstract] [Full Text] [Related]

  • 15. Comparative efficacy and safety of micronized fenofibrate and simvastatin in patients with primary type IIa or IIb hyperlipidemia.
    Farnier M, Bonnefous F, Debbas N, Irvine A.
    Arch Intern Med; 1994 Feb 28; 154(4):441-9. PubMed ID: 8117177
    [Abstract] [Full Text] [Related]

  • 16. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
    Jones PH, Hunninghake DB, Ferdinand KC, Stein EA, Gold A, Caplan RJ, Blasetto JW, Statin Therapies for Elevated Lipid Levels Compared Across Doses to Rosuvastatin Study Group.
    Clin Ther; 2004 Sep 28; 26(9):1388-99. PubMed ID: 15531001
    [Abstract] [Full Text] [Related]

  • 17. [Mid-term clinical study of the effectiveness of and tolerability to simvastatin ++ in dyslipidemic patients].
    Irace L, Aiello C, Papa A, Sannino A, Petraglia L, De Lucia R, Dragonetti C.
    Minerva Med; 1992 Dec 28; 83(12):815-8. PubMed ID: 1491761
    [Abstract] [Full Text] [Related]

  • 18. [Multicenter comparative study on safety, tolerance, and effectiveness of lovastatin combined or not with cholestyramine, and gemfibrozil combined or not with cholestyramine in the treatment of primary hypercholesterolemia].
    Jover E, Aranda JL, Nogués X, del Palacio A, Rubiés-Prat J.
    Med Clin (Barc); 1996 May 25; 106(20):776-9. PubMed ID: 8801396
    [Abstract] [Full Text] [Related]

  • 19. Low-dose simvastatin is safe in hyperlipidaemic renal transplant patients.
    Martinez Hernandez BE, Persaud JW, Varghese Z, Moorhead JF.
    Nephrol Dial Transplant; 1993 May 25; 8(7):637-41. PubMed ID: 8396749
    [Abstract] [Full Text] [Related]

  • 20. Effects of high-dose simvastatin on adrenal and gonadal steroidogenesis in men with hypercholesterolemia.
    Dobs AS, Schrott H, Davidson MH, Bays H, Stein EA, Kush D, Wu M, Mitchel Y, Illingworth RD.
    Metabolism; 2000 Sep 25; 49(9):1234-8. PubMed ID: 11016911
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.